We are live on
!
Find out more
ACM
Atika Capital Management Portfolio holdings
AUM
$796M
1-Year Est. Return
167.57%
This Fund
S&P 500
This Quarter
Est. Return
-13.06%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$340M
AUM Growth
-$218M
(-39%)
Cap. Flow
-$143M
Cap. Flow
% of AUM
-42.21%
Top 10 Holdings %
Top 10 Hldgs %
34.54%
Holding
111
New
25
Increased
14
Reduced
28
Closed
40
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
COUP
Coupa Software Incorporated
COUP
|
+$4.05M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
+$3.23M |
| 3 |
Vulcan Materials
VMC
|
+$3.14M |
| 4 |
Vanda Pharmaceuticals
VNDA
|
+$3.06M |
| 5 |
iRhythm Holdings
IRTC
|
+$2.54M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HubSpot
HUBS
|
+$9.06M |
| 2 |
Shake Shack
SHAK
|
+$6.55M |
| 3 |
PVTL
Pivotal Software, Inc.
PVTL
|
+$6.46M |
| 4 |
WWE
World Wrestling Entertainment
WWE
|
+$5.8M |
| 5 |
ECYT
Endocyte, Inc. Common Stock
ECYT
|
+$5.42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 35.3% |
| 2 | Technology | 15.08% |
| 3 | Communication Services | 7.07% |
| 4 | Consumer Discretionary | 6.11% |
| 5 | Materials | 2.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
argenx
ARGX
$52B
| $4.99M | 1.47% |
51,900
-11,730
| -18% | -$1.04M |
|
|
XYZ
27
Block Inc
XYZ
$48.9B
| $4.94M | 1.45% |
88,000
-17,000
| -16% | -$1.2M |
|
|
ALLK
28
DELISTED
Allakos
ALLK
| $4.7M | 1.38% |
90,000
-5,071
| -5% | -$254K |
|
29
Five Below
FIVE
$12B
| $4.66M | 1.37% |
45,500
+8,500
| +23% | +$939K |
|
30
Molina Healthcare
MOH
$10.2B
| $4.42M | 1.3% |
38,000
-10,000
| -21% | -$1.31M |
|
31
CALL
Ashland
ASH
$3.29B
| $4.4M | 1.3% |
+62,000
| New | +$4.78M |
|
32
Align Technology
ALGN
$12.4B
| $4.09M | 1.21% |
19,554
-446
| -2% | -$113K |
|
|
COUP
33
DELISTED
Coupa Software Incorporated
COUP
| $4.02M | 1.18% |
+64,000
| New | +$4.05M |
|
34
MongoDB
MDB
$28.8B
| $4.01M | 1.18% |
47,900
-100
| -0.2% | -$7.69K |
|
35
EPAM Systems
EPAM
$5.6B
| $3.97M | 1.17% |
34,200
| – | – |
|
36
Tandem Diabetes Care
TNDM
$1.38B
| $3.83M | 1.13% |
101,000
-14,000
| -12% | -$494K |
|
37
Teladoc Health
TDOC
$1.21B
| $3.82M | 1.12% |
77,000
-56,000
| -42% | -$3.43M |
|
|
GOOS
38
Canada Goose Holdings
GOOS
$856M
| $3.67M | 1.08% |
84,000
+28,000
| +50% | +$1.56M |
|
|
39
Vanda Pharmaceuticals
VNDA
$315M
| $3.4M | 1% |
+130,000
| New | +$3.06M |
|
40
Vertex Pharmaceuticals
VRTX
$119B
| $3.4M | 1% |
20,500
+2,500
| +14% | +$433K |
|
|
41
CALL
Five Below
FIVE
$12B
| $3.37M | 0.99% |
+32,900
| New | +$3.64M |
|
42
Martin Marietta Materials
MLM
$32.6B
| $3.27M | 0.96% |
19,000
-4,000
| -17% | -$710K |
|
43
CALL
Vail Resorts
MTN
$5.32B
| $3.16M | 0.93% |
+15,000
| New | +$3.71M |
|
|
44
Ashland
ASH
$3.29B
| $3.14M | 0.92% |
44,200
-39,000
| -47% | -$3.01M |
|
|
45
Vulcan Materials
VMC
$36.7B
| $3.06M | 0.9% |
+31,000
| New | +$3.14M |
|
|
LOXO
46
DELISTED
Loxo Oncology, Inc
LOXO
| $2.94M | 0.87% |
21,000
+4,000
| +24% | +$607K |
|
|
47
BioMarin Pharmaceuticals
BMRN
$11.6B
| $2.9M | 0.85% |
+34,000
| New | +$3.23M |
|
|
EXAS
48
CALL
DELISTED
Exact Sciences
EXAS
| $2.78M | 0.82% |
+44,100
| New | +$3.03M |
|
|
LKFT
49
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.75B
| $2.68M | 0.79% |
29,200
-35,900
| -55% | -$3.64M |
|
50
Zai Lab
ZLAB
$2.05B
| $2.58M | 0.76% |
+111,000
| New | +$2.06M |
|
Similar funds
AGA
RIM
ACM
CAM
LSA
GWA
HP
Atika Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, Atika Capital Management held 111 positions worth $340M, down 39% from $558M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Atika Capital Management withdrew a net $143M in Q4 2018, closing 40 positions and reducing 28 holdings. Its most notable exit was HubSpot, an estimated $9.06M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 37% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Atika Capital Management opened a new position in Coupa Software Incorporated worth $4.02M.
- Atika Capital Management's largest Q4 2018 buy was Coupa Software Incorporated: 64,000 shares worth $4.02M.
- Atika Capital Management added most to eHealth in Q4 2018, an estimated $2.5M increase.
- Atika Capital Management's biggest Q4 2018 reduction was NovoCure, cutting an estimated $4.99M.
- Atika Capital Management fully exited HubSpot in Q4 2018, selling an estimated $9.06M.
- Atika Capital Management's ten largest holdings make up 35% of its $340M portfolio in Q4 2018.
- Atika Capital Management opened 25 new positions and closed 40 in Q4 2018.
- Atika Capital Management's portfolio value fell 39% quarter-over-quarter to $340M.
Based on Atika Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.